Egetis Therapeutics AB (P0F) Q2 2026 Earnings Report
DE:P0F Q2 2026 EPS Results
- Actual EPS
- -EUR 0.02
- Consensus EPS
- -EUR 0.01
- Beat/Miss
- Missed by -EUR 0.01
- One Year Ago EPS
- -EUR 0.02
DE:P0F Q2 2026 Revenue Results
- Actual Revenue
- EUR 1.58M
- Expected Revenue
- EUR 1.83M
- Beat/Miss
- Missed by -EUR 254.29K
- YoY Revenue Growth
- +20.00%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/21/2026
- Time
- Before Open
- Conference Call
- Friday, August 21, 2026
DE:P0F Upcoming Earnings
Egetis Therapeutics AB's next earnings date is estimated for November 6, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:P0F Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 06, 2026 | 2026 (Q3) | -0.02- | -0.02 | ― | ― |
| Aug 21, 2026 | 2026 (Q2) | -0.01-0.02 | -0.02 | -17.62% (-0.00) | |
| Apr 29, 2026 | 2026 (Q1) | -0.02-0.02 | -0.02 | -41.18% (-0.01) | |
| Feb 26, 2026 | 2025 (Q4) | -0.02-0.03 | -0.03 | 2.58% (+0.00) | |
| Nov 25, 2025 | 2025 (Q3) | -0.02-0.02 | -0.03 | 18.73% (+0.00) | |
| Aug 21, 2025 | 2025 (Q2) | -0.02-0.02 | -0.02 | 12.13% (+0.00) | |
| Apr 30, 2025 | 2025 (Q1) | -0.02-0.02 | -0.02 | 34.62% (+0.01) | |
| Feb 26, 2025 | 2024 (Q4) | -0.02-0.03 | -0.03 | 5.20% (+0.00) | |
| Nov 08, 2024 | 2024 (Q3) | -0.03-0.03 | -0.03 | 18.21% (+0.01) | |
| Aug 22, 2024 | 2024 (Q2) | -0.03-0.02 | -0.03 | 24.84% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed